News & Views

December 1, 2022

Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience

November 30, 2022

Xerna™ TME Panel as a predictive biomarker in lung cancer

November 23, 2022

SITC 2022: some thoughts in review

November 8, 2022

Genialis Presents New Clinical Biomarker Findings at SITC, BioTechX

September 29, 2022

Genialis Updates ResponderID, Enhancing Data Flywheel for Improved Clinical Biomarker Discovery

May 26, 2022

Genialis’ ResponderID™ Named a Fast Company 2022 World Changing Idea

May 18, 2022

Genialis Renews ISO 27001 Certification for Fifth Year Running

Navicixizumab plus paclitaxel demonstrated promising clinical activity in bevacizumab-treated and -naive patients with platinum-resistant ovarian cancer, with manageable toxicity.

May 17, 2022

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

April 21, 2022

Genialis Releases Improved Version of Expressions for Faster, More Secure Multi-Omics Processing and Data Management

April 11, 2022

Genialis and OncXerna co-present their latest findings implicating the Xerna TME Panel as a pan-cancer diagnostic

April 4, 2022

Genialis ResponderID to Use Xerna™ TME Panel to Improve Targeted Therapy Selection

March 1, 2022

Inhibrx Selects Genialis ResponderID™ for Clinical Optimization Study of INBRX-109

January 11, 2022

Genialis AI platform speeds identification of biomarkers

November 2, 2021

Genialis Debuts ResponderID™ for Clinical Biomarker Discovery

October 22, 2021

Genialis Innovates Machine Learning Solutions for Clinical Biomarker Discovery

September 28, 2021

Leveraging AI and Machine Learning for smarter clinical trial design

June 17, 2021

Genialis Expands Support for Clinical Biomarker Discovery Platform

May 15, 2021

AI and the Lab of the Future

April 12, 2021

Genialis Presents Updated Results on AI-Enabled, RNA-Based Pan-Cancer Biomarker Platform at AACR

April 12, 2021

AACR 2021 Poster: RNA-Based Diagnostic Panel Matches TME Phenotype to Therapeutic Mechanism of Action in Colorectal Cancer

March 19, 2021

Genialis, BioLab Partner to Improve Precision Medicine Using Data Mining

November 10, 2020

Genialis Harnesses RNA-seq Platform to Advance Precision Medicine Discoveries

November 10, 2020

SITC 2020 Poster: Development of an RNA-based Diagnostic Platform Based on the Tumor Microenvironment Dominant Biology

October 5, 2020

AAIH Optimizing Real World Data for Therapeutic Development: Role of AI

June 10, 2020

Getting to know Bruce Lefker, Genialis SAB member

May 4, 2020

Transcriptomics in the Time of Corona

February 19, 2020

Rafael on The Personalized Diagnostics Podcast

January 22, 2020

Genialis and OncXerna Collaborate on Precision Medicine Initiative in Gastric Cancer

January 8, 2020

Genialis Advances Precision Medicine Solutions for Diseases of Unmet Need

October 31, 2019

Easing the “Informatics Bottleneck” Burden in Next-generation Sequencing

October 31, 2019

Thermo Fisher Scientific, Genialis Ink Comarketing Agreement for RNA-Seq Data Analysis

October 3, 2019

Actionable predictive signatures from public and proprietary data

September 27, 2019

Getting the most from RNA-seq in drug discovery

August 22, 2019

The Pdx1-Bound Swi/Snf Chromatin Remodeling Complex Regulates Pancreatic Progenitor Cell Proliferation and Mature Islet β-Cell Function

July 9, 2019

High Priests of RNA Assemble: Five Days of Science & Magic in Krakow

June 10, 2019

Poster: Analysis of CLIP data using iMaps

June 5, 2019

Gene Expression Signatures and Predictive Modelling in Combination Immunotherapy

May 1, 2019

Genialis Extends NGS Informatics Platform to Analyze Single Cell RNA-Sequencing Data

February 27, 2019

Roche + Genialis global partnership announcement, ASHG 2018

January 28, 2019

Genialis, a founding member of the AAIH

January 10, 2019

Human ESC-Derived Chimeric Mouse Models of Huntington’s Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation

January 7, 2019

Genialis Bolsters Scientific Advisory Board Ahead of IO Biomarker Platform Debut

November 27, 2018

Defining a Multi-Omics Target Discovery Framework for High-Risk Cancers

October 16, 2018

Genialis Expands Portfolio of Multi-Omics Data Analysis Workflows to Extend Applications for Drug Discovery

August 15, 2018

The Cancer Avatar Project: Using Targeted NGS to Analyze Circulating Tumor DNA

November 14, 2017

Genialis, Inc. Raises $2.3M Seed Round to Advance Visual Exploration of Genomics Data

October 10, 2017

Baylor, Genialis team up for next generation sequencing

Articles & Posts
Events
Posters & Publications
Press releases

Genialis Tweets Follow

Genialis builds in silico models of disease biology to advance discovery & de-risk development of novel therapeutics.

Genialis @genialis ·

6 Dec

On Episode 28 of #TalkingPrecisionMedicine Podcast, @aloktayi of @VibeBio joins host @rafecooks to discuss how #Vibebio is aiming to disrupt #drugdevelopment finance through stakeholder communities. Listen here 🔊 ➡️ https://buff.ly/3uw2tHk
#rarediseases #drugdiscovery #research

Reply on Twitter 1600214748594847744 Retweet on Twitter 1600214748594847744 2 Like on Twitter 1600214748594847744 8 Twitter 1600214748594847744

Genialis @genialis ·

28 Nov

Researchers in pursuit of serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks: https://www.nature.com/articles/s41598-022-23191-z

#GERDAwarenessWeek #GERD #GastroesophagealRefluxDisease #Biomarkers

Reply on Twitter 1597259460543934464 Retweet on Twitter 1597259460543934464 1 Like on Twitter 1597259460543934464 2 Twitter 1597259460543934464

Genialis @genialis ·

24 Nov

Happy Thanksgiving from Genialis!
#thanksgiving

Reply on Twitter 1595779464218148864 Retweet on Twitter 1595779464218148864 1 Like on Twitter 1595779464218148864 2 Twitter 1595779464218148864

Genialis @genialis ·

22 Nov

Pancreatic image bank expected to help advance diabetes research worldwide. Read the news here: https://www.eurekalert.org/news-releases/967972

#PancreaticCancer #Biomarkers #Protein #NewStudy

Reply on Twitter 1595051115330019332 Retweet on Twitter 1595051115330019332 Like on Twitter 1595051115330019332 Twitter 1595051115330019332

Genialis @genialis ·

18 Nov

Genialis is supporting CPMCRI scientists in a longitudinal study exploring the liquid biopsy approach for detecting circulating tumor DNA in cancer patients. Read more in the published paper: https://www.mdpi.com/2075-4426/12/11/1845 #CPMCRI #ctDNA

Reply on Twitter 1593535385795182593 Retweet on Twitter 1593535385795182593 Like on Twitter 1593535385795182593 1 Twitter 1593535385795182593

Media Categories